A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK | Zendy

Emma Taylor | Zendy; Abhijit M. Bal | Zendy; Indran Balakrishnan | Zendy; Nicholas M. Brown | Zendy; Phillipa Burns | Zendy; Marilyn Clark | Zendy; Mathew Diggle | Zendy; Hugo Donaldson | Zendy; Ian Eltringham | Zendy; Jonathan Folb | Zendy; Naomi J. Gadsby | Zendy; Mairi Macleod | Zendy; Natasha Ratnaraja | Zendy; Cheryl Williams | Zendy; Mandy Wootton | Zendy; Shiranee Sriskandan | Zendy; Neil Woodford | Zendy; Katie L. Hopkins | Zendy

Open Access

A prospective surveillance study to determine the prevalence of 16S rRNA methyltransferase-producing Gram-negative bacteria in the UK

Author(s) -

Emma Taylor,

Abhijit M. Bal,

Indran Balakrishnan,

Nicholas M. Brown,

Phillipa Burns,

Marilyn Clark,

Mathew Diggle,

Hugo Donaldson,

Ian Eltringham,

Jonathan Folb,

Naomi J. Gadsby,

Mairi Macleod,

Natasha Ratnaraja,

Cheryl Williams,

Mandy Wootton,

Shiranee Sriskandan,

Neil Woodford,

Katie L. Hopkins

Publication year - 2021

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkab186

Subject(s) - amikacin , microbiology and biotechnology , 16s ribosomal rna , acinetobacter baumannii , acinetobacter , biology , pseudomonas aeruginosa , antibiotics , medicine , antibiotic resistance , bacteria , genetics

To determine the prevalence of 16S rRNA methyltransferase- (16S RMTase-) producing Gram-negative bacteria in patients in the UK and to identify potential risk factors for their acquisition.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research